Abstract
The immune system does not normally react against self components. Originally, it was postulated that self-reactive cells were somehow deleted or blocked1. More recent thinking2,3 is that such cells are suppressed by regulatory networks similar to those limiting the immune response against non-self determinants. Both mechanisms may exist4,5. I describe here a type of suppression more closely related to the first postulate. In the in vitro, one-way, mixed lymphocyte reaction (MLR), cytotoxic T-lymphocyte precursor cells (CLP) from the responder population give rise to cytotoxic T-lymphocytes (CL) capable of lysing target cells from the stimulator population6–8. A sub-population of cells in the spleen of athymic nude mice can, when added to such cultures, inactivate CLP capable of recognizing either the H–2 antigens or TNP modifications of the nude spleen. Regarding the nude spleen cells, activation of self-react ve cells is being prevented.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Burnet, F. M. Cold Spring Harb. Symp. quant. Biol. 32, 1–8 (1967).
Cantor, H. & Gershon, R. K. Fedn Proc. 38, 2058–2064 (1979).
Cunningham, A. J. Transplanto Rev. 31, 23–43 (1976).
Claman, H. N. Cell. Immun. 48, 201–207 (1979).
Borel, Y., Kilham, L., Kurtz, S. E. & Reinisch, C. L. J. exp. Med. 151, 743–748 (1980).
Cerottini, J.-C. & Brunner, K. T. Adv. Immun. 18, 67–132 (1974).
Bach, F. H., Bach, M. L. & Sondei, P. M. Nature 259, 273–281 (1976).
Miller, R. G., Teh, H.-S., Harley, E. & Phillips, R. A. Immun. Rev. 35, 38–58 (1977).
Miller, R. G. & Derry, H. J. Immun. 122, 1502–1509 (1979).
Teh, H.-S., Harley, E., Phillips, R. A. & Miller, R. G. J. Immun. 118, 1049–1056 (1977).
Shearer, G. M., Rehn, T. G. & Schmitt-Verhulst, A. M. Transplanto Rev. 29, 222–250 (1976).
Doherty, P. C., Blanden, R. V. & Zinkernagel, R. M. Transplanto Rev. 29, 89–123 (1976).
Jerne, N. K. An. Immun. 125C, 373–389 (1974).
Muraoka, S. & Miller, R. G. J. exp. Med. 152, 54–71 (1980).
Miller, R. G. (in preparation).
Jerne, N. K. Eur. J. Immun, 1, 1–9 (1971).
Shearer, G. M. Eur. J. Immun. 4, 527–533 1974.
Teh, H.-S., Phillips, R. A. & Miller, R. G. J. Immun. 121, 1711–1717 (1978).
Miller, R. G. & Dunkley, M. Cell. Immun. 14, 284–302 (1974).
Porter, E. H. & Berry, R. J. Br. J. Cancer 17, 583–595 (1964).
Miller, R. G. & Phillips, R. A. J. cell. Physiol. 73, 191–201 (1969).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miller, R. An immunological suppressor cell inactivating cytotoxic T-lymphocyte precursor cells recognizing it. Nature 287, 544–546 (1980). https://doi.org/10.1038/287544a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/287544a0
This article is cited by
-
Correction of murine sickle cell disease by allogeneic haematopoietic cell transplantation with anti-3rd party veto cells
Bone Marrow Transplantation (2021)
-
A strategy to protect off-the-shelf cell therapy products using virus-specific T-cells engineered to eliminate alloreactive T-cells
Journal of Translational Medicine (2019)
-
Toward safer haploidnetical hematopoietic stem cell transplantation
Bone Marrow Transplantation (2019)
-
The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT
Bone Marrow Transplantation (2015)
-
Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers
Bone Marrow Transplantation (2014)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.